Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian R Walker

Showing results (1-10 of 218) with videos related to

Pageof 22
Sort By:
Hormone Research|February 5, 2003
Mineralocorticoid mechanismsBrian R Walker
Obesity Research|January 27, 2004
11beta-hydroxysteroid dehydrogenase type 1 in obesityBrian R Walker
The Proceedings of the Nutrition Society|March 9, 2007
Extra-adrenal regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioningBrian R Walker
European Journal of Endocrinology|November 7, 2007
Glucocorticoids and cardiovascular diseaseBrian R Walker
Drugs|August 31, 2013
11β-HSD1 inhibitors for the treatment of type 2 diabetes and cardiovascular diseaseAnna Anderson, Brian R Walker
Annals of the New York Academy of Sciences|December 7, 2006
Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic diseaseBrian R Walker, Ruth Andrew
Molecular and Cellular Endocrinology|March 18, 2004
11 beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndromeDeborah J Wake, Brian R Walker
Expert Opinion on Therapeutic Targets|December 4, 2003
11beta-hydroxysteroid dehydrogenase type 1 as a novel therapeutic target in metabolic and neurodegenerative diseaseBrian R Walker, Jonathan R Seckl
Trends in Endocrinology and Metabolism: TEM|November 3, 2004
11beta-hydroxysteroid dehydrogenase type 1 as a modulator of glucocorticoid action: from metabolism to memoryJonathan R Seckl, Brian R Walker
Hormone Molecular Biology and Clinical Investigation|December 2, 2014
The role and regulation of 11β-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndromeRoland H Stimson, Brian R Walker
Pageof 22

Showing results (1-10 of 218) with videos related to

Sort By:
Pageof 22
Hormone Research|February 5, 2003
Mineralocorticoid mechanismsBrian R Walker
Obesity Research|January 27, 2004
11beta-hydroxysteroid dehydrogenase type 1 in obesityBrian R Walker
The Proceedings of the Nutrition Society|March 9, 2007
Extra-adrenal regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioningBrian R Walker
European Journal of Endocrinology|November 7, 2007
Glucocorticoids and cardiovascular diseaseBrian R Walker
Drugs|August 31, 2013
11β-HSD1 inhibitors for the treatment of type 2 diabetes and cardiovascular diseaseAnna Anderson, Brian R Walker
Annals of the New York Academy of Sciences|December 7, 2006
Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic diseaseBrian R Walker, Ruth Andrew
Molecular and Cellular Endocrinology|March 18, 2004
11 beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndromeDeborah J Wake, Brian R Walker
Expert Opinion on Therapeutic Targets|December 4, 2003
11beta-hydroxysteroid dehydrogenase type 1 as a novel therapeutic target in metabolic and neurodegenerative diseaseBrian R Walker, Jonathan R Seckl
Trends in Endocrinology and Metabolism: TEM|November 3, 2004
11beta-hydroxysteroid dehydrogenase type 1 as a modulator of glucocorticoid action: from metabolism to memoryJonathan R Seckl, Brian R Walker
Hormone Molecular Biology and Clinical Investigation|December 2, 2014
The role and regulation of 11β-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndromeRoland H Stimson, Brian R Walker
Pageof 22